Ardelyx (ARDX) Priced

Developing therapies to control the progression of late-stage kidney disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $13.50 0.00 (0.0%)
First Day Return 0.8%
Return from IPO -3.6%
 
Ardelyx IPO News more
  • .
IPO Data
IPO File Date 05/19/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.3
Deal Size ($mm) 60
 
IPO Data
IPO Date 06/18/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.3
Deal Size ($mm) $60
 
Underwriters
more
Business Overview
Developing therapies to control the progression of late-stage kidney disease.
Developing therapies to control the progression of late-stage kidney disease.
more
Company Data
Headquarters Fremont, CA
Founded 2007
Employees 37
Website www.ardelyx.com
 

Performance vs. IPO Index (IPOUSA)